Your cart is currently empty!
SLU-PP 332
What is SLU-PP 332? SLU-PP-332 is a synthetic small molecule investigated for its activity as a pan-agonist of estrogen-related receptors (ERRα, ERRβ, and ERRγ). Preclinical studies have examined its effects on mitochondrial function, cellular respiration, and metabolic regulation—particularly in skeletal muscle models. Research indicates that activation of these receptors may mimic some of the cellular responses associated with endurance exercise, including increased energy expenditure and fat oxidation, without changes in physical activity or caloric intake. For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.
Description
| Chemical Formula | Proprietary small-molecule compound (not publicly disclosed) |
| Molecular Mass | Not publicly disclosed |
| CAS Number | Not publicly assigned |
| Form | Solid research compound |
| Shelf Life | 24 months (under recommended storage conditions) |
| Intended Use | For preclinical and in vitro research only |
| Storage | Store at −20 °C in a dry, light-protected environment |
In experimental research settings, SLU-PP-332 is utilized as a synthetic small-molecule agonist of estrogen-related receptor alpha (ERRα) to investigate transcriptional regulation of mitochondrial function and energy metabolism. Its activity supports studies focused on nuclear receptor signaling, metabolic gene expression, and cellular energy utilization.
Preclinical research applications commonly employ SLU-PP-332 to examine ERRα-mediated control of oxidative metabolism, mitochondrial biogenesis, and metabolic adaptation under controlled laboratory conditions. These investigations contribute to broader efforts aimed at understanding nuclear receptor–driven metabolic regulation in non-clinical research models.
Intended for laboratory research use only. Not for human or animal consumption, medical diagnosis, or therapeutic application.
Additional information
| Volume | 5MG |
|---|
Description
| Chemical Formula | Proprietary small-molecule compound (not publicly disclosed) |
| Molecular Mass | Not publicly disclosed |
| CAS Number | Not publicly assigned |
| Form | Solid research compound |
| Shelf Life | 24 months (under recommended storage conditions) |
| Intended Use | For preclinical and in vitro research only |
| Storage | Store at −20 °C in a dry, light-protected environment |
In experimental research settings, SLU-PP-332 is utilized as a synthetic small-molecule agonist of estrogen-related receptor alpha (ERRα) to investigate transcriptional regulation of mitochondrial function and energy metabolism. Its activity supports studies focused on nuclear receptor signaling, metabolic gene expression, and cellular energy utilization.
Preclinical research applications commonly employ SLU-PP-332 to examine ERRα-mediated control of oxidative metabolism, mitochondrial biogenesis, and metabolic adaptation under controlled laboratory conditions. These investigations contribute to broader efforts aimed at understanding nuclear receptor–driven metabolic regulation in non-clinical research models.
Intended for laboratory research use only. Not for human or animal consumption, medical diagnosis, or therapeutic application.
Additional information
| Volume | 5MG |
|---|
Reviews
There are no reviews yet.
Related products
-
Cagrilintide
$90.00 -
MOTS-C
$40.00 -
Retatrutide
Price range: $50.00 through $1,000.00 -
Semaglutide
Price range: $21.00 through $50.00 -
Survodutide
$165.00






Reviews
There are no reviews yet.